Periodic Reporting for period 2 - RESCUER (RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.)

What is the problem/issue being addressed?Some patients do and others do not benefit from combination therapies (chemotherapy combined with immune therapy or with targeted anti-angiogenesis treatment). We will study this by integrating multi-omics data from clinical trials...